Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

About this grant

The purpose of this notice of funding opportunity (NOFO) is to support research and/or preclinical development of highly efficacious vaccines against malaria - one of the deadliest mosquito-borne diseases - by capitalizing on recent technological innovations, particularly in structure-based immunogen design, improved formulations, and combination vaccines. The goal is to achieve long-lasting, highly effective protection that can save lives, strengthen public health security in the United States, and serve as a model for, or are potentially effective against, other mosquito-borne diseases.

Eligibility requirements

Eligible applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; Public and State controlled institutions of higher education; Private institutions of higher education; City or township governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; County governments; State governments; Public housing authorities/Indian housing authorities; For profit organizations other than small businesses; Native American tribal governments (Federally recognized); Independent school districts.

• Nonprofit
• Student
• Business

Contact information

• National Institutes of Health
• MalariaandOtherMosquitoBorneDiseases@mail.nih.gov
• 301-402-2541